[go: up one dir, main page]

BR0315319A - Terapias e procedimentos dentais com toxina botulìnica - Google Patents

Terapias e procedimentos dentais com toxina botulìnica

Info

Publication number
BR0315319A
BR0315319A BR0315319-3A BR0315319A BR0315319A BR 0315319 A BR0315319 A BR 0315319A BR 0315319 A BR0315319 A BR 0315319A BR 0315319 A BR0315319 A BR 0315319A
Authority
BR
Brazil
Prior art keywords
procedures
toxin
botulically
therapies
dental
Prior art date
Application number
BR0315319-3A
Other languages
English (en)
Inventor
Howard I Katz
Andrew M Blumenfeld
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BR0315319A publication Critical patent/BR0315319A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)

Abstract

"TERAPIAS E PROCEDIMENTOS DENTAIS COM TOXINA BOTULìNICA". A presente invenção refere-se a método para facilitar vários tratamentos, terapias e procedimentos dentais por meio da administração de uma toxina Clostridial a um músculo ou outro tecido na cabeça ou no pescoço de um paciente.
BR0315319-3A 2002-10-15 2003-10-14 Terapias e procedimentos dentais com toxina botulìnica BR0315319A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41878902P 2002-10-15 2002-10-15
US10/685,986 US20040115139A1 (en) 2002-10-15 2003-10-14 Botulinum toxin dental therapies and procedures
PCT/US2003/032841 WO2004035011A2 (en) 2002-10-15 2003-10-14 Botulinum toxin dental therapies and procedures

Publications (1)

Publication Number Publication Date
BR0315319A true BR0315319A (pt) 2005-08-16

Family

ID=32110188

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315319-3A BR0315319A (pt) 2002-10-15 2003-10-14 Terapias e procedimentos dentais com toxina botulìnica

Country Status (9)

Country Link
US (2) US20040115139A1 (pt)
EP (1) EP1551430A2 (pt)
JP (1) JP2006513994A (pt)
KR (1) KR20050061541A (pt)
AU (1) AU2003287155A1 (pt)
BR (1) BR0315319A (pt)
CA (1) CA2501856A1 (pt)
MX (1) MXPA05003936A (pt)
WO (1) WO2004035011A2 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000172A2 (en) * 2000-06-28 2002-01-03 Ira Sanders Methods for using tetanus toxin for benificial purposes in animals (mammals)
US20040104108A1 (en) * 2002-12-03 2004-06-03 Mason Robert Michael High capacity purification of thermally unstable compounds
US7311103B2 (en) * 2003-07-29 2007-12-25 Checkmate Holding Company, Llc Method for treating obstructive sleep apnea syndrome
US20100266638A1 (en) 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
US7811584B2 (en) * 2004-06-30 2010-10-12 Allergan, Inc. Multivalent clostridial toxins
US7514088B2 (en) * 2005-03-15 2009-04-07 Allergan, Inc. Multivalent Clostridial toxin derivatives and methods of their use
WO2006026780A1 (en) 2004-09-01 2006-03-09 Allergan, Inc. Degradable clostridial toxins
US8128940B2 (en) 2005-03-15 2012-03-06 Allergan, Inc. Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
US20060246093A1 (en) * 2005-04-13 2006-11-02 Biomed Est. Implant analog
US20080021437A1 (en) * 2006-04-27 2008-01-24 Boyd James P Enhancement of the efficacy of a clenching reduction device by augmenting with botulinum toxin type A
WO2011011513A1 (en) * 2009-07-21 2011-01-27 University Of Washington Through Its Center For Commercialization Inhibition of pathological bone formation
WO2011041483A2 (en) 2009-09-30 2011-04-07 Toxcure, Inc. Use of botulinum neurotoxin to treat substance addictions
US8696352B2 (en) 2011-09-15 2014-04-15 Lanfried Ortho Technology, Llc Intra-oral appliance and methods of using same
US9744000B2 (en) 2011-09-15 2017-08-29 Lanfried Ortho Technology, Llc Intra-oral appliance and methods of using same
EP2779939B1 (en) * 2011-11-15 2018-02-14 Trispera Dental Inc. Method and system for acquiring data from an individual for preparing a 3d model
US9005628B2 (en) 2012-10-04 2015-04-14 Dublin City University Biotherapy for pain
GB201312317D0 (en) 2013-07-09 2013-08-21 Syntaxin Ltd Cationic neurotoxins
US9216210B2 (en) 2013-12-23 2015-12-22 Dublin City University Multiprotease therapeutics for chronic pain
KR20160143654A (ko) 2014-02-21 2016-12-14 트리스페라 덴탈 아이엔씨. 증강 현실 치과 디자인 방법 및 시스템
US12004867B2 (en) 2014-11-06 2024-06-11 Shane Matt Three dimensional imaging of the motion of teeth and jaws
RU2733493C2 (ru) 2015-01-09 2020-10-02 Ипсен Байоинновейшн Лимитед Катионные нейротоксины
CA2988179A1 (en) * 2015-06-16 2016-12-22 Quantum Dental Technologies Inc. System and method of monitoring consumable use based on correlations with diagnostic testing
GB201517450D0 (en) 2015-10-02 2015-11-18 Ipsen Biopharm Ltd Method
GB201607901D0 (en) 2016-05-05 2016-06-22 Ipsen Biopharm Ltd Chimeric neurotoxins
EP3263710A1 (en) 2016-07-01 2018-01-03 Ipsen Biopharm Limited Production of activated clostridial neurotoxins
WO2018060351A1 (en) 2016-09-29 2018-04-05 Ipsen Biopharm Limited Hybrid neurotoxins
WO2019068888A1 (en) * 2017-10-06 2019-04-11 Ranoux Daniele USE OF BOTULINUM TOXIN FOR THE TREATMENT OF SUBJECTIVE ACOUPHENES
JP7186228B2 (ja) 2018-02-26 2022-12-08 イプセン バイオファーム リミテッド 非細胞毒性プロテアーゼの注入を案内するための超音波の使用
CN112955166A (zh) * 2018-09-13 2021-06-11 阿勒根公司 治疗咬肌肥大的方法
GB202103372D0 (en) 2021-03-11 2021-04-28 Ipsen Biopharm Ltd Modified clostridial neurotoxins

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183462A (en) * 1990-08-21 1993-02-02 Associated Synapse Biologics Controlled administration of chemodenervating pharmaceuticals
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
ES2309973T3 (es) * 1993-12-28 2008-12-16 Allergan, Inc. Uso de toxina botulinica para la fabricacion de un medicamento para reducir el dolor en la parte baja de la espalda.
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
DE69526340T2 (de) * 1994-05-09 2002-11-14 William J. Binder Botulinumtoxin ZUR REDUKTION VON Migraine -KOPFSCHMERZEN
US5670484A (en) * 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
GB9508204D0 (en) * 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US5721215A (en) * 1996-03-20 1998-02-24 Allergan Injectable therapy for control of muscle spasms and pain related to muscle spasms
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6164278A (en) * 1999-02-25 2000-12-26 Nissani; Moti Taste-based approach to the prevention of teeth clenching and grinding
US6358917B1 (en) * 1999-08-24 2002-03-19 Jean D. A. Carruthers Cosmetic use of botulinum toxin for treatment of downturned mouth
US6265379B1 (en) * 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) * 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) * 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US20020127247A1 (en) * 2000-11-17 2002-09-12 Allergen Sales, Inc. Modified clostridial neurotoxins with altered biological persistence
US20020192239A1 (en) * 2001-01-09 2002-12-19 Borodic Gary E. Use of botulinum toxin for the treatment of chronic facial pain

Also Published As

Publication number Publication date
WO2004035011A3 (en) 2004-09-23
MXPA05003936A (es) 2005-06-17
KR20050061541A (ko) 2005-06-22
EP1551430A2 (en) 2005-07-13
US20060018844A1 (en) 2006-01-26
AU2003287155A1 (en) 2004-05-04
CA2501856A1 (en) 2004-04-29
JP2006513994A (ja) 2006-04-27
WO2004035011A2 (en) 2004-04-29
US20040115139A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
BR0315319A (pt) Terapias e procedimentos dentais com toxina botulìnica
BRPI0410041A (pt) métodos para tratamento de dor de cabeça de sinusite
BR0013998A (pt) Uso de enzimas de quebra associadas a fago bacterial para o tratamento profilático e terapêutico de várias doenças
BRPI0407485A (pt) utilização de anticorpos anti-receptores de factor crescimento i semelhantes aos anti-insulina
BR0316906A (pt) administração do capsaicinoides
BR0210941A (pt) Terapia de combinação de oxazolidinonas substituìdas
HUP0102203A2 (hu) Optikailag tiszta (+)-norciszaprid alkalmazása apnoé, bulimia és más rendellenességek kezelésére alkalmas gyógyászati készítmények előállítására
BRPI0417370A (pt) composições de produtos botánicos marinhos para proporcionar nutrição a pele danificada por envelhecimento e meio ambiente
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
BR0012022A (pt) Composição adesiva monomérica, e, métodos para usar a composição, e para produzir uma composição adesiva com sabor
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
DK1305036T3 (da) Næringsmiddelsammensætning
NZ588648A (en) Suture line administration technique using botulinum toxins
WO2004004757A8 (en) Treatment for eye disorder
BR0211049A (pt) Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
PE20110711A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmaceuticamente aceptables de la misma
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
SE0102147D0 (sv) New methods
BR9812660A (pt) Composições e métodos para tratar distúrbios respiratórios
BR0201524A (pt) Tratamento de combinação para ansiedade e depressão
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
BR0108261A (pt) Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A , E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.